View Cardiol Therapeutics Inc. Class A CRDL stock quote prices, financial information, real-time forecasts, and company news from CNN.

Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. Given this risk, we thought we'd take a look at whether Cardiol ...

After the event, a full recording of the interview will be available on the Company's X channel (@CardiolRx) and Barchart's (@Barchart). Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a ...

Cardiol Therapeutics Inc (NASDAQ:CRDL) shares are trading lower by 18.4% to $1.60 Wednesday morning after the company announced a $13.5 million public offering of 8,437,500 common shares priced at ...

A downtrend has been apparent in Cardiol Therapeutics Inc. (CRDL) lately. While the stock has lost 8.8% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cardiol Therapeutics Inc. (CRDL) is a stock that can certainly grab the attention of ...

Detailed price information for Cardiol Therapeutics (CRDL-Q) from The Globe and Mail including charting and trades.

Results Demonstrate the Active Pharmaceutical Ingredient in Cardiol's Novel CRD-38 Formulation Attenuates Harmful Fat Distribution and Key Markers of Cardiac Inflammation and Remodelling Data ...

697,000 people die from heart disease every year in the United States – that is one in every five deaths. In fact, cardiovascular disease is the number one killer for most Americans per the CDC.

TORONTO, May 14, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic ...